Craig J. Beavers, PharmD, BCCP, BCPS-AQ Cardiology, CACP, FACC, has been awarded the 2025 Distinguished Cardiovascular Team ...

If you know someone with a disability, offer to help them find a vaccination site or explore in-home options. Many face ...

Topline data were announced from a phase 3 trial evaluating CagriSema (cagrilintide/semaglutide) in overweight or obese patients with type 2 diabetes.

Atogepant vs placebo for the preventative treatment of migraine alleviated migraine symptoms across 3 clinical trials on day 1.

The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.

A significant percentage of patients with RA and ANCA positivity were also diagnosed with AAV, with GPA being the most common subtype.

Compared to the general population, individuals with incident hospital-based cannabis use disorder care have an increased risk of death.

Highlighted potential long-term benefits of INB-200. As of October 18, 2024, five patients remained alive, three patients had ...

There is an inverse bidirectional association between cancer and dementia, a relationship that holds across cancer and dementia subtypes.

The best cold medicine won't cure your virus, but it will help you manage your symptoms. These OTC options should stay ...

Ongoing Phase 1 and Phase 2 clinical programs continue to exhibit long-term durable remissions in hard-to-treat cancers, including glioblastoma (GBM) and 100% of treated Acute Myeloid Leukemia (AML) ...

Biologics Licensing Application (BLA) for clemidsogene lanparvovec (RGX-121) submitted and on track for potential FDA approval 2H 2025; strategic partnership with Nippon Shinyaku aims to expand ...